|
Status |
Public on Sep 25, 2019 |
Title |
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
31631026 |
|
Submission date |
Feb 13, 2018 |
Last update date |
Jan 13, 2020 |
Contact name |
Jamie Anastas |
E-mail(s) |
jamie.anastas@childrens.harvard.edu, jamieanastas@gmail.com
|
Phone |
16174298539
|
Organization name |
Boston Children's Hospital
|
Department |
Newborn Medicine
|
Lab |
Yang Shi
|
Street address |
300 Longwood Ave
|
City |
Boston, MA |
State/province |
United States of America |
ZIP/Postal code |
02115 |
Country |
USA |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (30)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE110570 |
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [ChIP-seq] |
GSE110571 |
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] |
|
Relations |
BioProject |
PRJNA434015 |